Neuronetics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
/ 
Frequently asked questions
To buy Neuronetics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Neuronetics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Neuronetics Inc. is STIM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Neuronetics Inc. has its primary listing on NASDAQ. You can trade Neuronetics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Neuronetics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Neuronetics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Neuronetics Inc..